Small Cap Stocks Down Under 8 July 2022: Integrated Research (ASX:IRI)

It’s been more than two years since we last covered Integrated Research (ASX: IRI). We liked the company’s product and revenue model, but couldn’t bring ourselves to give it four stars, given the mediocre performance of the share price. We put it down to the large stake of its co-founder, which keeps many institutional investors away, and that its performance appeared to be deteriorating. We also observed that the stock was high-priced. Two years on, things have gone from bad to worse for shareholders, but things seem to be looking up for FY23. And following the recent Tech crunch, IRI’s valuation is now too hard to resist